Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A21194 | 25486027 | Eur J Gastroenterol Hepatol | Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A21195 | 25486007 | PLoS One | A vaccine targeted at CETP alleviates high fat and high cholesterol diet-induced atherosclerosis and non-alcoholic steatohepatitis in rabbit. | 2014 | Details |
| A21203 | 25481429 | Lipids Health Dis | Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients. | 2014 | Details |
| A21204 | 25480592 | J Huazhong Univ Sci Technolog Med Sci | Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography. | 2014 | Details |
| A21205 | 25479248 | Nutrients | The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
| A21213 | 25477264 | J Hepatol | Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. | 2014 | Details |
| A21215 | 25475859 | Hepatobiliary Pancreat Dis Int | New insight of vitamin D in chronic liver diseases. | 2014 | Details |
| A21220 | 25470250 | PLoS One | Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. | 2014 | Details |
| A21227 | 25469015 | World J Gastroenterol | Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis? | 2014 | Details |
| A21230 | 25468829 | Int J Obes (Lond) | Fetuin-A: a novel link between obesity and related complications. | 2014 | Details |
| A21231 | 25468788 | Med Hypotheses | Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C. | 2014 | Details |
| A21232 | 25468486 | Transl Res | Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. | 2014 | Details |
| A21235 | 25468160 | Lancet | Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. | 2014 | Details |
| A21236 | 25463079 | Atherosclerosis | Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness. | 2014 | Details |
| A21250 | 25456097 | Metabolism | Leptin in nonalcoholic fatty liver disease: a narrative review. | 2014 | Details |
| A21252 | 25454300 | Clin Liver Dis | Contemporary assessment of hepatic fibrosis. | 2014 | Details |
| A21254 | 25453980 | Peptides | The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. | 2014 | Details |
| A21263 | 25450212 | J Hepatol | Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity. | 2014 | Details |
| A21264 | 25450203 | J Hepatol | Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21265 | 25450180 | Biochim Biophys Acta | Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. | 2014 | Details |
| A21267 | 25446569 | Eur J Pharmacol | Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway. | 2014 | Details |
| A21270 | 25445395 | J Hepatol | Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease. | 2014 | Details |
| A21271 | 25445207 | Transl Res | Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease. | 2014 | Details |
| A21272 | 25443620 | Liver Int | The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. | 2015 | Details |
| A21273 | 25443068 | Surg Obes Relat Dis | Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese. | 2014 | Details |
| A21284 | 27356366 | Bull Acad Natl Med | [Not Available]. | 2014 | Details |
| A21289 | 25430494 | J Clin Pathol | Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis. | 2014 | Details |
| A21290 | 25429984 | Hepatol Res | Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients. | 2014 | Details |
| A21292 | 25429378 | Scand J Gastroenterol | Noninvasive characterization of graft steatosis after liver transplantation. | 2014 | Details |
| A21299 | 25426570 | J Hypertens | The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: findings from a cross-sectional study. | 2015 | Details |
| A21303 | 25421042 | Mol Med Rep | Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. | 2014 | Details |
| A21315 | 25412688 | Curr Vasc Pharmacol | Incretin-Based Antidiabetic Agents for the Management of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A21316 | 25412597 | Wien Klin Wochenschr | Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease. | 2014 | Details |
| A21318 | 25410681 | BMC Gastroenterol | High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma. | 2014 | Details |
| A21320 | 25407526 | Int J Mol Sci | Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage. | 2014 | Details |
| A21328 | 25402369 | Hormones (Athens) | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis. | 2014 | Details |
| A21331 | 25400438 | World J Gastroenterol | Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2014 | Details |
| A21333 | 25400436 | World J Gastroenterol | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. | 2014 | Details |
| A21337 | 25394651 | Pol Arch Med Wewn | A composite model including visfatin, tissue polypeptide-specific antigen, hyaluronic acid, and hematological variables for the diagnosis of moderate-to-severe fibrosis in nonalcoholic fatty liver disease: a preliminary study. | 2014 | Details |
| A21344 | 25386164 | Front Endocrinol (Lausanne) | Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments. | 2014 | Details |
| A21345 | 25386083 | World J Gastroenterol | Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. | 2014 | Details |
| A21346 | 25386071 | World J Gastroenterol | Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. | 2014 | Details |
| A21347 | 25386056 | World J Gastroenterol | MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. | 2014 | Details |
| A21348 | 25386055 | World J Gastroenterol | Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease. | 2014 | Details |
| A21355 | 25381118 | Obes Surg | Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. | 2015 | Details |
| A21359 | 25378958 | Hepat Med | Surgical treatment of nonalcoholic fatty liver disease in severely obese patients. | 2014 | Details |
| A21364 | 25372401 | PLoS One | Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. | 2014 | Details |
| A21378 | 25360469 | Oral Dis | A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. | 2014 | Details |
| A21385 | 25356042 | World J Gastroenterol | Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation. | 2014 | Details |
| A21387 | 25354830 | Dig Dis Sci | Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis. | 2014 | Details |
| A21392 | 25352725 | Bioinformation | Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non- Alcoholic Fatty Liver Disease. | 2014 | Details |
| A21396 | 25350950 | J Diabetes | Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study. | 2014 | Details |
| A21397 | 25350286 | PLoS One | Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study. | 2014 | Details |
| A21404 | 25347188 | PLoS One | Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains. | 2014 | Details |
| A21408 | 25344588 | J Lipid Res | Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. | 2014 | Details |
| A21411 | 25339832 | World J Gastroenterol | Liver resection and metabolic disorders: an undescribed mechanism leading to postoperative mortality. | 2014 | Details |
| A21413 | 25339808 | World J Gastroenterol | Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning? | 2014 | Details |
| A21414 | 25339807 | World J Gastroenterol | Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. | 2014 | Details |
| A21429 | 25326152 | J Gastroenterol | Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. | 2014 | Details |
| A21439 | 25317812 | Eur Rev Med Pharmacol Sci | The impact of small doses of LPS on NASH in high sucrose and high fat diet induced rats. | 2014 | Details |
| A21447 | 25311610 | Nutr Res | Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21448 | 25311381 | Clin Gastroenterol Hepatol | Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. | 2014 | Details |
| A21451 | 25310357 | Mol Med Rep | Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice. | 2014 | Details |
| A21454 | 25309079 | World J Gastroenterol | Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease. | 2014 | Details |
| A21455 | 25309067 | World J Gastroenterol | Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. | 2014 | Details |
| A21458 | 25306468 | Transplant Rev (Orlando) | Liver disease in kidney transplant recipients. | 2014 | Details |
| A21463 | 25302830 | Radiology | Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis. | 2014 | Details |
| A21464 | 25302781 | Hepatology | Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity. | 2015 | Details |
| A21465 | 25302503 | PLoS One | Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans. | 2014 | Details |
| A21466 | 25300437 | Kidney Blood Press Res | Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients. | 2014 | Details |
| A21470 | 25297827 | Hepatol Res | Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study. | 2014 | Details |
| A21471 | 25296089 | Arq Gastroenterol | Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study. | 2015 | Details |
| A21475 | 25295245 | Biomed Res Int | Autophagy and non-alcoholic fatty liver disease. | 2014 | Details |
| A21479 | 25292174 | Obesity (Silver Spring) | Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. | 2014 | Details |
| A21480 | 25291138 | J Clin Gastroenterol | Coffee and liver health. | 2015 | Details |
| A21483 | 25289058 | Exp Ther Med | Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis. | 2014 | Details |
| A21484 | 25285192 | Frontline Gastroenterol | Non-alcoholic fatty liver disease: a practical approach to treatment. | 2014 | Details |
| A21485 | 25284781 | Cell Rep | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 2014 | Details |
| A21489 | 25281863 | J Hepatol | Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. | 2014 | Details |
| A21491 | 25281858 | J Hepatol | TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. | 2014 | Details |
| A21494 | 25278691 | World J Gastroenterol | Non-alcoholic fatty liver disease: what the clinician needs to know. | 2014 | Details |
| A21495 | 25278690 | World J Gastroenterol | Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. | 2014 | Details |
| A21509 | 25267215 | Aliment Pharmacol Ther | Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. | 2014 | Details |
| A21512 | 25265201 | Nanotoxicology | Intratracheal exposure to multi-walled carbon nanotubes induces a nonalcoholic steatohepatitis-like phenotype in C57BL/6J mice. | 2014 | Details |
| A21516 | 25260964 | BMC Gastroenterol | Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease. | 2014 | Details |
| A21518 | 25259621 | Scand J Gastroenterol | A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease. | 2014 | Details |
| A21520 | 25256692 | J Magn Reson Imaging | Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. | 2014 | Details |
| A21521 | 25256357 | J Nutr Biochem | Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism. | 2014 | Details |
| A21525 | 25253959 | World J Gastroenterol | Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
| A21531 | 25251399 | Hepatology | Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. | 2015 | Details |
| A21549 | 25238938 | Pathol Res Pract | Histopathological aspects of liver under variable food restriction: has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development? | 2014 | Details |
| A21551 | 25234945 | J Hepatol | Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis. | 2014 | Details |
| A21553 | 25233430 | Biochem Soc Trans | Deciphering non-alcoholic fatty liver disease through metabolomics. | 2014 | Details |
| A21575 | 25217800 | Exp Mol Pathol | Alcoholic and non-alcoholic steatohepatitis. | 2014 | Details |
| A21577 | 25216184 | PLoS One | Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. | 2014 | Details |
| A21581 | 25211791 | Practitioner | Improving outcomes for patients with obesity. | 2014 | Details |
| A21582 | 25211789 | Practitioner | Detecting patients with cirrhosis in primary care. | 2014 | Details |
| A21586 | 25205520 | Biochim Biophys Acta | Creatine reduces hepatic TG accumulation in hepatocytes by stimulating fatty acid oxidation. | 2014 | Details |
| A21590 | 25203315 | Hepatology | ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. | 2015 | Details |
| A21596 | 25195551 | J Hepatol | Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. | 2014 | Details |